- Home
- MMU vs PHAR Comparison
MMU vs PHAR Comparison
Compare MMU & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMU
- PHAR
- Stock Information
- Founded
- MMU 1992
- PHAR 1988
- Country
- MMU United States
- PHAR Netherlands
- Employees
- MMU N/A
- PHAR N/A
- Industry
- MMU Investment Managers
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- MMU Finance
- PHAR Health Care
- Exchange
- MMU Nasdaq
- PHAR Nasdaq
- Market Cap
- MMU 562.0M
- PHAR 627.5M
- IPO Year
- MMU N/A
- PHAR N/A
- Fundamental
- Price
- MMU $10.43
- PHAR $7.76
- Analyst Decision
- MMU
- PHAR Strong Buy
- Analyst Count
- MMU 0
- PHAR 2
- Target Price
- MMU N/A
- PHAR $33.50
- AVG Volume (30 Days)
- MMU 170.7K
- PHAR 6.7K
- Earning Date
- MMU 01-01-0001
- PHAR 10-24-2024
- Dividend Yield
- MMU 4.92%
- PHAR N/A
- EPS Growth
- MMU N/A
- PHAR N/A
- EPS
- MMU N/A
- PHAR N/A
- Revenue
- MMU N/A
- PHAR $285,745,000.00
- Revenue This Year
- MMU N/A
- PHAR $20.89
- Revenue Next Year
- MMU N/A
- PHAR $11.15
- P/E Ratio
- MMU N/A
- PHAR N/A
- Revenue Growth
- MMU N/A
- PHAR 30.64
- 52 Week Low
- MMU $8.60
- PHAR $6.65
- 52 Week High
- MMU $10.45
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- MMU 44.83
- PHAR 42.78
- Support Level
- MMU $10.31
- PHAR $7.70
- Resistance Level
- MMU $10.46
- PHAR $8.28
- Average True Range (ATR)
- MMU 0.08
- PHAR 0.40
- MACD
- MMU 0.02
- PHAR -0.07
- Stochastic Oscillator
- MMU 46.15
- PHAR 32.73
About MMU Western Asset Managed Municipals Fund Inc.
Western Asset Managed Municipals Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is to maximize current income exempted from federal income tax as is consistent with the preservation of principal. It predominantly invests in long-term investment grade municipal debt securities issued by state and local governments, political subdivisions, agencies, and public authorities (municipal obligations). Under normal market conditions, a majority of its total assets are invested in municipal obligations rated investment grade at the time of investment.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.